# A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

> **NCT07363330** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Zhongnan Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Cervical Cancer
- Recurrent
- Metastatic

## Interventions

- **DRUG:** Utidelone plus Toripalimab

## Key facts

- **NCT ID:** NCT07363330
- **Lead sponsor:** Zhongnan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07363330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07363330, "A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07363330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*